BioMarin Pharmaceutical Inc. (BMRN)
Sector: | Health Care |
Super Investor Stats: | |
Ownership count: | 2 |
Ownership rank: | 348 |
% of all portfolios: | 0.039% |
Hold Price * : | $70.29 |
History | Portfolio Manager | Activity | Share change | % change to portfolio ▼ | |
Q3  2024 | |||||
≡ | Viking Global Investors | Add 38.08% | 2,689,729 | 0.69 | |
≡ | Torray Funds | Sell 100.00% | 16,855 | 0.21 | |
Q2  2024 | |||||
≡ | Viking Global Investors | Add 10.09% | 647,276 | 0.20 | |
≡ | Torray Funds | Add 13.61% | 2,019 | 0.03 | |
Q1  2024 | |||||
≡ | Daniel Loeb - Third Point | Sell 100.00% | 385,000 | 0.56 | |
≡ | Viking Global Investors | Add 31.23% | 1,526,834 | 0.50 | |
≡ | Torray Funds | Add 1.15% | 168 | 0.00 | |
Q4  2023 | |||||
≡ | Daniel Loeb - Third Point | Buy | 385,000 | 0.56 | |
≡ | Viking Global Investors | Add 15.99% | 673,998 | 0.24 | |
≡ | Torray Funds | Add 3.14% | 446 | 0.01 | |
Q3  2023 | |||||
≡ | Torray Funds | Add 29.51% | 3,241 | 0.05 | |
≡ | Viking Global Investors | Add 1.41% | 58,671 | 0.02 | |
≡ | Dodge & Cox | Add 0.53% | 47,000 | 0.00 | |
Q2  2023 | |||||
≡ | Viking Global Investors | Add 91.68% | 1,988,168 | 0.71 | |
≡ | Torray Funds | Add 0.96% | 104 | 0.00 | |
≡ | Dodge & Cox | Add 0.36% | 32,200 | 0.00 | |
Q1  2023 | |||||
≡ | Viking Global Investors | Reduce 58.88% | 3,105,003 | 1.42 | |
≡ | Torray Funds | Add 0.40% | 43 | 0.00 | |
Q4  2022 | |||||
≡ | Viking Global Investors | Add 3.42% | 174,456 | 0.09 | |
≡ | Dodge & Cox | Reduce 1.89% | 170,400 | 0.02 | |
≡ | Torray Funds | Reduce 4.12% | 466 | 0.01 | |
Q3  2022 | |||||
≡ | Viking Global Investors | Add 0.92% | 46,571 | 0.02 | |
≡ | Dodge & Cox | Add 0.21% | 18,500 | 0.00 | |
≡ | Torray Funds | Reduce 2.33% | 269 | 0.00 | |
Q2  2022 | |||||
≡ | Viking Global Investors | Add 34.65% | 1,300,200 | 0.49 | |
≡ | Torray Funds | Reduce 0.16% | 18 | 0.00 | |
Q1  2022 | |||||
≡ | Viking Global Investors | Add 30.75% | 882,446 | 0.28 | |
≡ | Torray Funds | Reduce 5.31% | 650 | 0.01 | |
Q4  2021 | |||||
≡ | Viking Global Investors | Buy | 2,869,947 | 0.74 | |
≡ | Torray Funds | Reduce 25.40% | 4,166 | 0.05 | |
≡ | Lee Ainslie - Maverick Capital | Sell 100.00% | 5,833 | 0.00 | |
Q3  2021 | |||||
≡ | Dodge & Cox | Add 6.08% | 515,300 | 0.04 | |
≡ | Torray Funds | Add 1.26% | 204 | 0.00 | |
≡ | Lee Ainslie - Maverick Capital | Reduce 9.98% | 647 | 0.00 | |
Q2  2021 | |||||
≡ | Dodge & Cox | Add 25.51% | 1,721,565 | 0.16 | |
≡ | Lee Ainslie - Maverick Capital | Buy | 6,480 | 0.01 | |
≡ | Torray Funds | Add 0.88% | 142 | 0.00 | |
Q1  2021 | |||||
≡ | Torray Funds | Reduce 75.72% | 50,070 | 0.59 | |
≡ | Dodge & Cox | Add 22.19% | 1,225,735 | 0.12 | |
Q4  2020 | |||||
≡ | Dodge & Cox | Add 33.33% | 1,380,965 | 0.17 | |
≡ | Torray Funds | Reduce 3.31% | 2,263 | 0.03 | |
Q3  2020 | |||||
≡ | Dodge & Cox | Add 78.10% | 1,816,835 | 0.23 | |
≡ | Torray Funds | Add 26.48% | 14,320 | 0.20 | |
Q2  2020 | |||||
≡ | Viking Global Investors | Sell 100.00% | 1,453,625 | 0.64 | |
≡ | Torray Funds | Reduce 10.69% | 6,472 | 0.15 | |
≡ | Dodge & Cox | Reduce 7.73% | 195,000 | 0.04 | |
Q1  2020 | |||||
≡ | Torray Funds | Add 7.14% | 4,037 | 0.08 | |
≡ | Viking Global Investors | Reduce 10.37% | 168,114 | 0.07 | |
≡ | Dodge & Cox | Reduce 14.71% | 435,000 | 0.07 | |
Q4  2019 | |||||
≡ | Torray Funds | Reduce 72.02% | 145,450 | 2.11 | |
≡ | Viking Global Investors | Reduce 46.97% | 1,436,365 | 0.57 | |
≡ | Dodge & Cox | Buy | 2,956,325 | 0.34 | |
Q3  2019 | |||||
≡ | Viking Global Investors | Add 18.06% | 467,753 | 0.16 | |
≡ | Torray Funds | Add 0.47% | 954 | 0.01 | |
Q2  2019 | |||||
≡ | Viking Global Investors | Reduce 49.50% | 2,538,558 | 0.98 | |
≡ | Torray Funds | Reduce 8.67% | 19,086 | 0.17 | |
Q1  2019 | |||||
≡ | Torray Funds | Reduce 2.03% | 4,552 | 0.04 | |
Q4  2018 | |||||
≡ | Torray Funds | Reduce 5.32% | 12,632 | 0.13 | |
Q2  2013 | |||||
≡ | Meridian Contrarian Fund | Sell 100.00% | 40,700 | 0.38 | |
Q1  2013 | |||||
≡ | Meridian Contrarian Fund | Reduce 69.03% | 90,700 | 0.85 | |
Q4  2012 | |||||
≡ | Meridian Contrarian Fund | Reduce 60.99% | 205,400 | 1.63 | |
Q2  2012 | |||||
≡ | Meridian Contrarian Fund | Add 9.35% | 28,800 | 0.18 | |
Q1  2012 | |||||
≡ | Meridian Contrarian Fund | Reduce 3.51% | 11,200 | 0.06 | |
Q4  2011 | |||||
≡ | Meridian Contrarian Fund | Reduce 8.49% | 29,600 | 0.15 | |
Q1  2011 | |||||
≡ | Meridian Contrarian Fund | Reduce 51.54% | 371,000 | 1.07 | |
Q3  2010 | |||||
≡ | Meridian Contrarian Fund | Reduce 9.56% | 76,100 | 0.21 | |
Q1  2010 | |||||
≡ | Meridian Contrarian Fund | Add 20.83% | 137,200 | 0.35 | |
Q3  2009 | |||||
≡ | Meridian Contrarian Fund | Buy | 658,700 | 1.33 | |
Q2  2009 | |||||
≡ | Bill & Melinda Gates Foundation Trust | Sell 100.00% | 104,856 | 0.02 | |
Q1  2009 | |||||
≡ | Bill & Melinda Gates Foundation Trust | Buy | 104,856 | 0.02 |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.